Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 October 2005, Vol. 106, No. 7, pp. 2409-2416.
Prepublished online as a Blood First Edition Paper on June 14, 2005; DOI 10.1182/blood-2005-03-0854.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-03-0854v1
106/7/2409    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, X.
Right arrow Articles by Howard, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, X.
Right arrow Articles by Howard, Z.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted March 1, 2005
Accepted May 31, 2005

Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic cell maturation and trafficking

Xin Chen*, Takaya Murakami, Joost J Oppenheim, and Zack Howard

Basic Research Program, SAIC-Frederick, Inc., Frederick, Maryland, USA
Laboratory of Molecular Immunoregulation, Center for Cancer research, National Cancer Institute, Frederick, Maryland, USA

* Corresponding author; email: xinc{at}mail.ncifcrf.gov.

Triptolide (TPT) is a chemically defined, potent immunosuppressive compound isolated from an anti-inflammatory Chinese herbal medicine. TPT has been reported to inhibit autoimmunity, allograft rejection and GVHD, and its efficacy was previously attributed to the suppression of T cells. Since dendritic cells (DCs) play a major role in the initiation of T cell-mediated immunity, we studied the effects of TPT on the phenotype, function and migration of human monocyte-derived DC. TPT-treatment, over a pharmacological concentration range, inhibited the LPS-induced phenotypic changes, characteristic of mature DC and the production of IL-12p70. Consequently the allostimulatory functions of DCs were impaired by TPT treatment. Furthermore, the calcium mobilization and chemotactic responses of LPS-stimulated-DC to SLC/CCL21 were significantly lower in TPT-treated than untreated DC, in association with lower CCR7 and higher CCR5 expression. Egress of Langerhans cells (LCs) from explanted mouse skin in response to MIP-3beta/CCL19 was arrested by TPT. In vivo administration of TPT markedly inhibited hapten (FITC)-stimulated migration of mouse skin LCs to the draining lymph nodes. These data provide new insight into the mechanism of action of TPT and indicate that the inhibition of maturation and trafficking of DC by TPT contributes to its immunosuppressive effects.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. A. Martin, D. L. Kurkowski, A. M. Valentino, and F. Santiago-Schwarz
Increased Intracellular, Cell Surface, and Secreted Inducible Heat Shock Protein 70 Responses Are Triggered during the Monocyte to Dendritic Cell (DC) Transition by Cytokines Independently of Heat Stress and Infection and May Positively Regulate DC Growth
J. Immunol., July 1, 2009; 183(1): 388 - 399.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F.-c. Lin, Y. Peng, L. A. Jones, P. H. Verardi, and T. D. Yilma
Incorporation of CD40 Ligand into the Envelope of Pseudotyped Single-Cycle Simian Immunodeficiency Viruses Enhances Immunogenicity
J. Virol., February 1, 2009; 83(3): 1216 - 1227.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-R. Pan, H.-C. Chang, Y.-C. Wu, C.-C. Huang, and W.-C. Hung
Tubocapsanolide A Inhibits Transforming Growth Factor-{beta}-activating Kinase 1 to Suppress NF-{kappa}B-induced CCR7
J. Biol. Chem., January 30, 2009; 284(5): 2746 - 2754.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
A. Vojdani and J. Erde
Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Tumor Immunity, Autoimmunity and Alloreactive Immunity (III)
Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 309 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Wang, R. Han, I. Lee, A. S. Hancock, G. Xiong, M. D. Gunn, and W. W. Hancock
Permanent Survival of Fully MHC-Mismatched Islet Allografts by Targeting a Single Chemokine Receptor Pathway
J. Immunol., November 15, 2005; 175(10): 6311 - 6318.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020